Explore / Preprint
PreprintOpen access

Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape

Luppi AI, Hansen JYiD, Adapa RiD, Carhart-Harris RLiD, Roseman LiD, Timmermann CiD, Golkowski DiD, Golkowski DiD, Ranft A, Ilg R, Jordan D, Bonhomme ViD, Vanhaudenhuyse AiD, Demertzi A, Jaquet O, Bahri MA, Alnagger NLiD, Cardone P, Peattie ARDiD, Manktelow AE, de Araujo DB, Sensi SL, Owen AMiD, Naci L, Menon DK, Misic B, Stamatakis EA

Jul 13, 2022License: open accessUnited Kingdom, Canada, United States, Germany, Belgium, Brazil, Italy, Ireland1 citationsDOI: 10.1101/2022.07.12.499688

Abstract

To understand how pharmacological interventions can exert their powerful effects on brain function, we need to understand how they engage the brain’s rich neurotransmitter landscape. Here, we bridge microscale molecular chemoarchitecture and pharmacologically-induced macroscale functional reorganisation, by relating the regional distribution of 19 neurotransmitter receptors and transporters obtained from Positron Emission Tomography, and the regional changes in functional MRI connectivity induced by 10 different mind-altering drugs: propofol, sevoflurane, ketamine, LSD, psilocybin, DMT, ayahuasca, MDMA, modafinil, and methylphenidate. Our results reveal that psychoactive drugs exert their effects on brain function by engaging multiple neurotransmitter systems. The effects of both anaesthetics and psychedelics on brain function are organised along hierarchical gradients of brain structure and function. Finally, we show that regional co-susceptibility to pharmacological interventions recapitulates co-susceptibility to disorder-induced structural alterations. Collectively, these results highlight rich statistical patterns relating molecular chemoarchitecture and drug-induced reorganisation of the brain’s functional architecture.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinMDMAKetamineLSDAyahuascaDMT

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.